UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048357
Receipt number R000053953
Scientific Title Analysis of factors associated with Crohn's Disease activity and evaluation of the efficacy of improving sleep disturbances on maintenance of remission
Date of disclosure of the study information 2022/07/15
Last modified on 2022/07/12 17:23:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of factors associated with Crohn's Disease activity and evaluation of the efficacy of improving sleep disturbances on maintenance of remission

Acronym

Association between Crohn's disease activity and sleep status

Scientific Title

Analysis of factors associated with Crohn's Disease activity and evaluation of the efficacy of improving sleep disturbances on maintenance of remission

Scientific Title:Acronym

Association between Crohn's disease activity and sleep status

Region

Japan


Condition

Condition

Crohn's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assess Crohn's disease activity and clarify its relationship to sleep status, stress, and quality of life, with objective indicators. Furthermore, we will provide patient guidance to improve sleep disturbance and investigate whether it is effective in maintaining remission.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Association between disease activity and sleep status in Crohn's disease.

Key secondary outcomes

(1) Relationship between disease activity and stress in Crohn's disease
(2) Relationship between disease activity and quality of life in Crohn's disease
(3) Changes in sleep status after sleep guidance
(4) Changes in disease activity after sleep guidance


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Only one in-person sleep improvement instruction session (approximately 15 minutes).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with Crohn's disease aged 18 years or older who are regular visitors to Fukuoka University Hospital

Key exclusion criteria

Patients with the following conditions are excluded: 1. psychiatric disorders, 2. sleep-related diseases such as severe insomnia and sleep apnea syndrome, 3. severe cardiac, liver, or renal diseases, 4. dementia, and 5. scheduled for surgery such as bowel resection or after surgery within 3 months, 6. difficult to answer the questionnaire, 7. otherwise judged as inappropriate by the physician in charge.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Fumihito
Middle name
Last name Hirai

Organization

Fukuoka University Faculty of Medicine

Division name

Department of Gastroenterology and Medicine

Zip code

8180180

Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka city, Fukuoka

TEL

0928011011

Email

fuhirai@cis.fukuoka-u.ac.jp


Public contact

Name of contact person

1st name Ashizuka
Middle name
Last name Shinya

Organization

Fukuoka University Faculty of Medicine

Division name

Department of Gastroenterology and Medicine

Zip code

8180180

Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka city, Fukuoka

TEL

0928011011

Homepage URL


Email

ashizuka@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka University Faculty of Medicine

Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka city, Fukuoka

Tel

0928011011

Email

fuhirai@cis.fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 06 Month 28 Day

Date of IRB

2022 Year 07 Month 11 Day

Anticipated trial start date

2022 Year 08 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry

2026 Year 06 Month 30 Day

Date trial data considered complete

2026 Year 09 Month 30 Day

Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 07 Month 12 Day

Last modified on

2022 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053953